The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...
Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.
Dr. Dina Radenkovic, CEO of Gameto, identifies the main contributors to the gap in in women's health innovation.